Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 151 | 91 | 53 |
| Accounts receivable | -467 | -359 | -102 |
| Other Working Capital | -1,621 | -5,202 | 48 |
| Other Operating Activity | -9,443 | -5,424 | -1,292 |
| Operating Cash Flow | $-11,380 | $-10,894 | $-1,292 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -424 | -14 | -22 |
| Purchase Sale Intangibles | N/A | 0 | -7 |
| Investing Cash Flow | $-424 | $-14 | $-29 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 0 | 12,069 | 400 |
| Debt Repayment | -20 | N/A | N/A |
| Common Stock Issued | 1,667 | 14,234 | 3,398 |
| Other Financing Activity | 382 | -1,020 | -121 |
| Financing Cash Flow | $2,029 | $25,283 | $3,678 |
| Beginning Cash Position | 16,732 | 2,357 | 0 |
| End Cash Position | 6,956 | 16,732 | 2,357 |
| Net Cash Flow | $-9,775 | $14,375 | $2,357 |
| Free Cash Flow | |||
| Operating Cash Flow | -11,380 | -10,894 | -1,292 |
| Capital Expenditure | -424 | -14 | -29 |
| Free Cash Flow | -11,804 | -10,908 | -1,321 |